The new WHO classification for acute myeloid leukemias and myelodysplastic syndromes:: Is it better than the FAB system?

被引：0
|
作者：
Löffler, H [1 ]
Haferlach, T [1 ]
机构：
[1] Univ Munich, Grosshaden, Med Klin & Poliklin 3, Munich, Germany
来源：
MEDIZINISCHE WELT | 2000年 / 51卷 / 11期
关键词：
acute myeloid leukemia; prognosis; cytomorphology; cytogenetic; WHO-classification;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since 25 years the FAB (French-American-British) classification was used for acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS). Now the WHO published a new proposal that is primary hosed on cytogenetic and molecular markers. In parallel, the history of the AML evolving from on MDS or therapy-related is taken into account. Dysplastic features ore also analyzed for further categories. The blast count for AML is newly defined to be more than 20%. This WHO proposal points out in the light direction. Its value for therapy, prognosis and its clinial relevance for a single patient has to be investigated prospectively.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [21] SECONDARY MYELODYSPLASTIC SYNDROMES AND ACUTE LEUKEMIAS
    ZEIDMAN, A
    BENDAYAN, D
    MITTELMAN, M
    HAEMATOLOGIA, 1995, 27 (01) : 23 - 28
  • [22] Immunophenotyping of acute leukemias and myelodysplastic syndromes
    Orfao, A
    Ortuño, F
    de Santiago, M
    Lopez, A
    Miguel, JS
    CYTOMETRY PART A, 2004, 58A (01) : 62 - 71
  • [23] Increased caspase activity in myelodysplastic syndromes and secondary acute myeloid leukemias.
    Kliche, KO
    Clement, JH
    Kunert, C
    Fricke, HJ
    Höffken, K
    BLOOD, 1998, 92 (10) : 419A - 419A
  • [24] Myelodysplastic syndromes according to FAB and WHO classification. Single center experience
    Haus, O
    Kotlarek-Haus, S
    Potoczek, S
    Czarnecka, M
    Duszenko, E
    Makowska, I
    Mirowska, N
    Kuliczkowski, K
    NEOPLASMA, 2006, 53 (02) : 136 - 143
  • [25] FABHELP - A RULE-BASED CONSULTATION PROGRAM FOR FAB CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    SHIFMAN, MA
    LABORATORY MEDICINE, 1991, 22 (09) : 639 - 643
  • [26] MYELODYSPLASTIC SYNDROMES AND THEIR RELATIONSHIPS TO ACUTE MYELOID LEUKEMIAS - DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PROBLEMS
    HAUSMANN, K
    RACZ, K
    DULLMANN, J
    GROSSCHUPFF, G
    WEH, HJ
    HOSSFELD, DK
    ONKOLOGIE, 1983, 6 (05): : 220 - 220
  • [27] AZACITIDINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS: A SINGLE CENTER EXPERIENCE
    Michallet, M.
    Champigneulle, C.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Nicolini, F.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Wattel, E.
    Ranchon, F.
    Rioufol, C.
    HAEMATOLOGICA, 2012, 97 : 275 - 276
  • [28] FAB CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES - MERITS AND CONTROVERSIES
    VERHOEF, GEG
    PITTALUGA, S
    DEWOLFPEETERS, C
    BOOGAERTS, MA
    ANNALS OF HEMATOLOGY, 1995, 71 (01) : 3 - 11
  • [29] BIPHENOTYPIC MATURATION OF MYELOID CELLS IN MYELODYSPLASTIC SYNDROMES AND LEUKEMIAS
    SCHMALZL, F
    LECHLEITNER, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (02) : 400 - 401
  • [30] The WHO classification of the myelodysplastic syndromes
    Bain, B
    EXPERIMENTAL ONCOLOGY, 2004, 26 (03) : 166 - 169
12345